[ SPOREs:
|
|
|
|
|
|
|
|
|
|
|
|
|
]
Ovarian SPOREs
Ovarian cancer is the second most common gynecological cancer in women, but ranks first (above endometrial cancer) in cancer deaths. Approximately 20,180 new ovarian cancers will be diagnosed in the United States in the year 2006 and about 15,310 women will die from this disease. The high mortality rate stems from an overall lack of early symptoms or screening methods for the disease. As a result, most ovarian cancer patients are diagnosed with advanced stage disease. Women with a family history of either breast, ovarian, or non-polyposis colon cancer are at an increased risk for developing ovarian cancer. The Ovarian Cancer SPORE program was initiated in 1999 with the funding of four sites. The relatively low incidence of this disease (as compared to other cancers, such as breast cancer), as well as the team concept of the SPORE program, has resulted in a number of Inter-SPORE activities aimed at developing much needed early detection, screening, prevention, and therapeutic tools for ovarian cancer. These supplemental activities are being performed in collaboration with a number of other NCI programs, including Avon Progress for Patients (PFP) Partnership, the Cancer Genetics Network (CGN), the Early Detection Research Network (EDRN), the Division of Cancer Prevention's Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screening Trial and the NCI Intramural Program.
To view the associated abstract, click on the name/address below.
Robert C. Bast, Jr., M.D.
University of Texas, MD Anderson Cancer Center
1515 Holcombe Blvd., Box 355
Houston, TX 77030
Tel: (713) 792-7743
Fax: (713) 792-7864
For more information on this specific SPORE's institution, please visit: http://www.mdanderson.org/Departments/ovarianspore/
|
Robert F. Ozols, M.D., Ph.D.
Fox Chase Cancer Center
333 Cottman Ave.
Philadelphia, PA 19111
Tel: (215) 728-2673
Fax: (215) 728-5346
For more information on this specific SPORE's institution, please visit: http://www.fccc.edu/research/SPORE.html
|
Nicole Urban, Sc.D.
Fred Hutchinson Cancer Research Center
Cancer Prevention Program
1100 Fairview Ave., North
Box 19024, M2-B230
Seattle, WA 98109-1024
Tel: (206) 667-4677
Fax: (206) 667-7264
For more information on this specific SPORE, please visit: www.pocrc.org
|
Daniel Cramer, M.D., Sc.D.
Brigham and Women's Hospital
Ob/Gyn Epidemiology Center
221 Longwood Ave.
Boston, MA 01225
Tel: (617) 732-4895
Fax: (617)732-4899
For more information on this specific SPORE's institution, please visit:
http://www.dfhcc.harvard.edu/spores/ovarian/
|
Edward E. Partridge, M.D.
University of Alabama at Birmingham
618 South 20th Street
538 Old Hillman Bldg., Room 538
Birmingham, Alabama 35233-7333
Tel: 205.934.4986
Fax: 205.975.6174
|
|
|